BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24009270)

  • 1. The effects of tumor location on diagnostic criteria for canine malignant peripheral nerve sheath tumors (MPNSTs) and the markers for distinction between canine MPNSTs and canine perivascular wall tumors.
    Suzuki S; Uchida K; Nakayama H
    Vet Pathol; 2014 Jul; 51(4):722-36. PubMed ID: 24009270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of electron microscopy to classify canine perivascular wall tumors.
    Palmieri C; Avallone G; Cimini M; Roccabianca P; Stefanello D; Della Salda L
    Vet Pathol; 2013 Mar; 50(2):226-33. PubMed ID: 22865645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical evaluation of canine peripheral nerve sheath tumors and other soft tissue sarcomas.
    Chijiwa K; Uchida K; Tateyama S
    Vet Pathol; 2004 Jul; 41(4):307-18. PubMed ID: 15232130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant peripheral nerve sheath tumors and spindle cell sarcomas: an immunohistochemical analysis of multiple markers.
    Giangaspero F; Fratamico FC; Ceccarelli C; Brisigotti M
    Appl Pathol; 1989; 7(2):134-44. PubMed ID: 2471540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of claudin-1 in canine peripheral nerve sheath tumours and perivascular wall tumours. Immunohistochemical study.
    Jakab C; Gálfi P; Jerzsele Á; Szabó Z; Németh T; Sterczer Á; Rusvai M; Ózsvári L
    Histol Histopathol; 2012 Jul; 27(7):905-17. PubMed ID: 22648546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors.
    Nonaka D; Chiriboga L; Rubin BP
    J Cutan Pathol; 2008 Nov; 35(11):1014-9. PubMed ID: 18547346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of canine cutaneous perivascular wall tumors: morphologic, phenotypic and clinical characterization.
    Avallone G; Helmbold P; Caniatti M; Stefanello D; Nayak RC; Roccabianca P
    Vet Pathol; 2007 Sep; 44(5):607-20. PubMed ID: 17846233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Heterogeneity of Canine Cutaneous Peripheral Nerve Sheath Tumors: A Drawback in the Diagnosis Refinement.
    Teixeira S; Amorim I; Rêma A; Faria F; Gärtner F
    In Vivo; 2016 11-12; 30(6):819-827. PubMed ID: 27815467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline cutaneous nerve sheath tumours: histological features and immunohistochemical evaluations.
    Mandara MT; Fabriani E; Pavone S; Pumarola M
    Res Vet Sci; 2013 Oct; 95(2):548-55. PubMed ID: 23659741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine perivascular wall tumors: high prognostic impact of site, depth, and completeness of margins.
    Avallone G; Boracchi P; Stefanello D; Ferrari R; Rebughini A; Roccabianca P
    Vet Pathol; 2014 Jul; 51(4):713-21. PubMed ID: 24048324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The controversial histologic classification of canine subcutaneous whorling tumours: The path to perivascular wall tumours.
    Avallone G; Stefanello D; Ferrari R; Roccabianca P
    Vet Comp Oncol; 2020 Mar; 18(1):3-8. PubMed ID: 31778274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Malignant Peripheral Nerve Sheath Tumor.
    Luzar B; Falconieri G
    Surg Pathol Clin; 2017 Jun; 10(2):337-343. PubMed ID: 28477884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors.
    Otsuka H; Kohashi K; Yoshimoto M; Ishihara S; Toda Y; Yamada Y; Yamamoto H; Nakashima Y; Oda Y
    Pathol Res Pract; 2018 Mar; 214(3):417-425. PubMed ID: 29482987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Analysis of Head and Neck and Non-Head and Neck Malignant Peripheral Nerve Sheath Tumors.
    Patel TD; Shaigany K; Fang CH; Park RC; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):113-20. PubMed ID: 26408559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutation of neu oncogene in animal peripheral nerve sheath tumors.
    Stoica G; Tasca SI; Kim HT
    Vet Pathol; 2001 Nov; 38(6):679-88. PubMed ID: 11732802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial malignant peripheral nerve sheath tumor: a rare and challenging diagnosis.
    Allison KH; Patel RM; Goldblum JR; Rubin BP
    Am J Clin Pathol; 2005 Nov; 124(5):685-92. PubMed ID: 16203275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth Factors and COX2 Expression in Canine Perivascular Wall Tumors.
    Avallone G; Stefanello D; Boracchi P; Ferrari R; Gelain ME; Turin L; Tresoldi E; Roccabianca P
    Vet Pathol; 2015 Nov; 52(6):1034-40. PubMed ID: 25795373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
    Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP
    Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry for trimethylated H3K27 in the diagnosis of malignant peripheral nerve sheath tumours.
    Asano N; Yoshida A; Ichikawa H; Mori T; Nakamura M; Kawai A; Hiraoka N
    Histopathology; 2017 Feb; 70(3):385-393. PubMed ID: 27580378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100-negative epithelioid malignant peripheral nerve sheath tumor with possible perineurial differentiation.
    Yamashita K; Funauchi Y; Hayakawa K; Ae K; Matsumoto S; Ikuta K; Nishida Y; Ueno T; Shimoyama Y; Hiruta N; Machinami R; Kawachi H; Takeuchi K
    Virchows Arch; 2022 Jun; 480(6):1269-1275. PubMed ID: 34635937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.